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Summary
We present evidence that a 480G“ )-A transition in the 
coding region of the P-glucuronidase gene, which results 
in an aspartic-acid-to-asparagine substitution at amino 
acid position 152 (D152N), produces a pseudodefi­
ciency allele (GUSBp) that leads to greatly reduced levels 
of P-glucuronidase activity without apparent deleterious 
consequences. The 480G~>A mutation was found ini­
tially in the pseudodeficient mother of a child with mu­
copolysaccharidosis VII (MPSVII), bu t it was not on her 
disease-causing allele, which carried the L176F muta­
tion. The 480G-+A change was also present in an unre­
lated individual with another MPSYII allele who had 
unusually low P~glucuronidase activity, but whose clini­
cal symptoms were probably unrelated to P-glucuroni­
dase deficiency. This individual also had an R357X mu­
tation, probably on his second allele. We screened 100 
unrelated normal individuals for the 480G-*A mutation 
with a PCR method and detected one carrier. Reduced 
p-glucuronidase activity following transfection of COS 
cells with the D152N cDNA supported the causal rela­
tionship between the D152N allele and pseudo defi­
ciency. The mutation reduced the fraction of expressed 
enzyme that was secreted. Puls e-chase experiments indi­
cated that the reduced activity in COS cells was due to 
accelerated intracellular turnover of the D152N enzyme. 
They also suggested that a potential glycosylation site 
created by the mutation is utilized in ~ 5 0 %  of the en­
zyme expressed.
Introduction
Human p-glucuronidase (E.C.3.2.1.31) is a lysosomal 
enzyme involved in the degradation of glucuronic acid 
containing glycosaminoglycans. The human p-glucuron-
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idase cDNA and the human (3-glucuronidase gene 
(GUSB) have been cloned and characterized (Oshima et 
aL 1987; Miller et al. 1990). At least seven unprocessed 
pseudogenes were detected in the human genome
(Shipley et al. 1993b; Vervoort et al. 1993). Glycosyla­
tion sites and C-terminal processing of the protein have 
been studied using transient transfection of COS7 cells 
(Islam et al. 1993; Shipley et al. 1993a). Deficiency of 
P-glucuronidase causes the autosomal recessive disorder 
mucopolysaccharidosis VII (MPSVII) or Sly syndrome 
(Sly et al. 1973). Patients can be divided in groups on 
the basis of the clinical manifestation of the disease (Nel­
son et al. 1982; Sewell et al. 1982), All affected individu­
als have in common the presence of storage material 
in the lysosomes, elevated glycosaminoglycan excretion, 
and a p-glucuronidase activity of 0 % - 2 % of average 
normal control values when measured with the synthetic 
substrate 4-methylumbelliferyl-P-D-glucuronide.
For many lysosomal enzymes, healthy individuals 
have been observed with an in vitro enzyme activity 
reduced to the range of activities seen in enzyme-defi­
cient patients, but with no evidence of deficient degrada­
tion of natural substrates in vivo. This condition has 
been termed “pseudodeficiency55 and has been reviewed 
recently (Zlotogora et al. 1983; Thomas 1994). In most 
pseudodeficiencies the low enzyme activity is probably 
also present in vivo but is thought to exceed a certain 
minimal threshold (threshold model). Thus, when tested 
with a loading assay, pseudodeficient cells generally be­
have as normal. In some cases, the low enzyme activity 
toward artificial substrates used in diagnosis is not found 
toward natural substrates. In these cases, the pseudode­
ficiency is explained as a change in substrate specificity 
rather than a decreased amount of enzyme. So far, all 
pseudo deficiencies studied at the molecular genetic level 
result from allelic mutations (Gieselmann et al. 1989; 
Dlott et al. 1990; Triggs-Raine et al. 1992; Cao et al.
1993).
The cases studied here include a phenotypically nor­
mal Spanish mother (Mrs. S.) of an MPSVII child (E.S.) 
who was the subject of an earlier report after she was 
found to have a low p-glucuronidase activity (6 % - 1 0 % 
of controls) (Chabas et al. 1991). However, her fibro-
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blasts  showed 35S-sulfate incorporation and chase assays 
sim ilar to controls. She had a normal excretion pattern 
o f  glycosaminoglycan. It was concluded that Mrs. S, was Chase M 0 10 24 
a com pound heterozygote for a P-glucuronidase pseudo- 
deficiency allele (GUSBp), which she did not transmit to 
h e r  MPSVII offspring, and a genuine (i-glucuronidase 
deficiency allele (MPSVII), which she did transmit to 
h e r  son with MPSVIL The second case (B.G.) (case 1 
described by Bernsen et al. 1987) was reported as an 
atypical MPSVII patient. Residual enzyme activity of 
B .G , and his affected sister was relatively high (3 % -5 %  
o f  controls). No mucopolysacchariduria was observed, 
a n d  the clinical findings, which might have been attrib­
u te d  to MPSVII (coarse fades, mental retardation, and 
epilepsy), were also present in a sibling with P~glucuroni- 
d a se  activity in the heterozygote range. These findings 
led  us to suspect that this patient had a GUSBp/MPSVII 
genotype with clinical symptoms unrelated to MPSVIL 
Patien t B.G. and his deficient sister both showed granu­
la tion  in polymorphonuclear leukocytes not seen in the 
sibling with enzyme activity in the heterozygote range.
T h e  meaning of this granulation remains unclear (Bern­
sen  et a l  1987).
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Figu re I Metabolic labeling and pulse chase of wild-type and 
D152N fS~Glucuronidase. COS cells were transfected as described in 
the note to table 1 . At 50 h after transfection, COS cells were labeled 
with Trans3SS4abel for '1 h and chased in unlabeled media for the 
hours indicated. Then, p-glucuronidase was immunoprecipitated by 
goat anti-human p-glucuronidase antibody and subjected to SDS- 
PAGE and fiuorography (upper panel). The bands in each lane were 
then scanned using a LKB 2202 Ultra Scan Laser Densitometer. The 
areas under the peaks of the scan are presented as relative intensity 
in the lower panel. Blackened areas are from cells* while unblackened 
areas are from media.
Material and Methods
Total RNA Isolation, RT-PCR, DNA Isolation and 
PCR Amplification
and loaded on an 8 % polyacrylamide gel, with or w ith­
out 5% glycerol and with 0.5 X or 1 X TBE-buffer,
Total RNA was prepared using described procedures Gels were run overnight at constant power (5 or 10  W),
(Chomczynski and Sacchi 1987). RT-PCR was per- at room temperature or at 4°C. Double-stranded PCR
form ed using the Gene Amp RNA PCR kit (Perkin- products amplified from cDNA and genomic DNA were
Elmer Cetus). Detailed protocols will be described directly sequenced with Sequenase 2.0 (United States
elsewhere (R. Vervoort and W. Lissens, unpublished in- Biochemicals), 
form ation). Genomic DNA of fibroblasts, leukocytes,
a n d  peripheral blood cells was prepared using standard p . A , .
procedures (Kunkel et al. 1977). Exon 3 was partially 0 Y™°r iSm nays®
amplified from genomic DNA with PCR (Saiki et al. ^he  1766T/C (T or C at cDNA position 1766) and
'1988). We used the sense primer 3 f described by Shipley 1972C/T (C or T at cDNA position 1972) polymor-
e t  al. (1993fc>) and a new antisense primer, HUG10, phisms were detected in the mRNA and in the genomic
w ith  sequence 5'-AGGTGTCAGTCAGGTATTGG-3' DNA by usinS PCR-based methods. In the presence of
(cDNA position 603-584). The sense primer RAF 44 is the 1766C  polymorphic allele, a BsaAI  site is created in
described in figure 1. Cycling conditions were as follows: exon 11 > wWch was detected in PCR fragments spanning
denaturation at 94°C, annealing at 63°C, and extension this nucleotide amplified from total RNA, and in the
a t  72°C. Forty cycles were used to amplify the RAF44- l l f -1  l r  fragment amplified from genomic DNA (Shipley
H UG 10 fragment and 35 cycles to amplify the 3f- et al. 1993b). This restriction site is absent in the pres-
H U G 10 fragment. Cycling times were 30 s for fragment ence of the 1766T polymorphism. The 1972C/T poly
RAF44-HUG10 and 1 min for fragment 3f-HUG10. A 
final extension was used at 72°C for 7 min,
SSCP Analysis and Sequence Analysis
To amplify fragments for SSCP analysis of the cDNA, 
35S-dATP and 35S-dCTP (1,000 Ci/mmol, Amersham) 
were incorporated during PCR. SSCP analysis (Orita et 
al. 1989) was performed using a combination of meth­
ods described elsewhere. Samples were heat denatured
morphism in exon 12 was detected in the RAF 17- 
HUG16 fragment, which was amplified from total RNA 
and from genomic DNA. The RAF'17 primer (sense,
5 ' -T C AC AAT GTTT GG AA A AC AGGC-3', cDNA posi­
tion 1950-1971) introduces an H aelll  restriction site in 
the PCR product amplified from the 1972C allele, but 
not from the 1972T allele. The HUG16 primer has se­
quence 5'-CCGTGAACAGTCCAGGAGGC-3' (anti-
sense), with cDNA position 2 072 -2053 .
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Express/on Studies
Expression studies in COS7 cells, were performed as 
described elsewhere (Oshima et al. 1987). Site-directed 
mutagenesis was performed as described elsewhere 
(Shipley et al. 1993#), using the Sculptor™ kit (Amer- 
sham).
Results
Detection of the DI52N Mutation in the 
Pseudodefidency Allele
Total RNA and genomic DNA were prepared from 
cultured fibroblasts of Mrs. S. and E.S. of the first family. 
The coding region of the cDNA was amplified with PCR 
and screened for mutations with PAGE to detect length 
changes and/or heteroduplexes. Since no abnormal frag­
ments were detected with PAGE, SSCP analysis of PCR- 
amplified fragments was performed. Only one fragment 
showed an abnormal pattern on SSCP gels* Different 
running conditions were used but disclosed no addi­
tional changes. Direct sequencing showed the MPSVII 
child (E.S.) to be homozygous for a C-to-T transition at 
cDNA position 552 (552C -T) in exon 3, predicting a 
leucine-to-phenylalanine substitution at amino acid po­
sition 176 (L176F). Mrs. S. was heterozygous for this 
L176F allele. The presence of both a G (normal) and an 
A (mutant) at cDNA position 480 in exon 3 indicated 
that she was also heterozygous at this position, This 
480G~>A substitution predicts an aspartic-acid-to-as- 
paragine change at position 152 (D152N). Genomic 
analysis of exon 3 of Mrs. S. and of E.S. confirmed these 
results (fig. 2). Sequencing of overlapping fragments, 
spanning the complete coding region of the cDNA, of 
both individuals did not disclose additional changes 
from the normal sequence.
The L176F mutation was shown elsewhere to be the 
only change in two American Mennonite siblings with 
the MPSVII phenotype (Wu et al. 1994), The indepen­
dent segregation of the D152N and L176F mutations in 
the S. family shows they are on different alleles (fig, 2 ). 
Thus, Mrs. S. is a compound heterozygote for the 
MPSVII allele and another allele with a D152N change, 
the postulated pseudodeficiency allele. Comparison of 
the intensity of the bands on a sequencing gel at the 
position of the mutated nucleotides indicates that both 
alleles are present in comparable amounts in the fi-gluc- 
uronidase mRNA of Mrs. S. (data not shown).
Two polymorphisms have been described in the p- 
glucuronidase coding region that are helpful in haplo- 
type analysis. These are 1766T/C in exon 11 (no amino 
acid change) and 1972C/T in exon 12 (P/L649). By se­
quencing, we determined those polymorphisms for Mrs. 
S. and E.S., and we deduced the haplotype of the GUSBp
allele of Mrs. S. (nt 480A, 552C, 1766C, 1972C) and 
that of the MPSVII allele (480G, 552T, 1766C, 1972T),
Comparison of band intensities at the position of the 
1972C/T polymorphism confirmed that the GUSBp and 
the MPSVII alleles are present in almost equal amounts 
in the (J-glucuronidase mRNA of Mrs. S.
From the Dutch patient (B.G.) only frozen leukocytes 
were available, from which genomic DNA was pre­
pared, By direct sequencing of exon 3> we found that 
B.G. was a carrier of the D152N change, which we had 
shown to be present on the postulated pseudodeficiency 
allele of Mrs. S. Since we expected B.G. to carry another 
inactivating allele based on his low (J-glucuronidase ac­
tivity in comparison to normal controls, PCR-amplified 
exons (Shipley et al. 19936) were screened for mutations 
found in MPSVII alleles. This analysis indicated that
B.G, was heterozygous for a C-to-T transition at cDNA 
position 1095 (1095C~*T) in exon 7, replacing an argi­
nine codon with a termination codon (R357X) (data not 
shown). This substitution was previously described in a 
black American patient (Shipley et al. 1993b). We also 
found it in homozygous form in one of our Belgian
MPSVII patients (V.D.P.). Since neither RNA from B.G. 
nor DNA from other members of his family were avail­
able, we were unable to prove that B.G,’s D152N and 
R357X changes are on different alleles. PCR-based hap­
lotype analysis at the polymorphic positions 1766C/T 
and 1972C/T showed that both alleles of B.G. had the 
1766C/1972C  haplotype.
In order to estimate the frequency of the postulated 
GUSBp allele, we used a PCR-based method to screen 
100 unrelated normal Belgian individuals for the 
480G-»A nucleotide change (fig. 3). We found one car­
rier of this substitution, allowing a rough estimate of the 
allele frequency at 0.5% . PCR-based haplotype analysis 
showed this carrier was heterozygous for a 1766T/ 
1972C and a 1766C/1972C allele.
Properties of the DI52N Enzyme Expressed in COS Cells
The mutant cDNA encoding the D152N mutant en­
zyme was produced by in vitro mutagenesis, was sub” 
cloned into the expression vector pJC119, and was ex­
pressed in COS cells. Table 1 shows that the level of 
total activity expressed in COS cells from the mutant 
cDNA was only 27% that seen in COS cells transfected 
with the wild-type cDNA. Furthermore, the fraction of 
total expressed enzyme that was secreted was smaller 
(19%) than that secreted following transfection with the 
wild-type cDNA (30%). To determine whether N H 4C1 
would divert more newly synthesized enzyme from lyso- 
somes to the secretory pathway (as seen with the wild- 
type enzyme), both wild-type and D152N transfected 
cells were exposed to 15 mM N H 4C1 for 5 0 -74  h after 
transfection (in the presence of mannose-6-phosphate to 
prevent recapture of secreted enzyme). The secretion of 
the wild-type enzyme was doubled, while the total wild- 
type enzyme produced increased only 4.5%. The secre-
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wild-type enzyme. First, the amount of m utant enzyme 
synthesized during the labeling period is comparable to 
the amount of wild-type enzyme. Second, the m utant 
enzyme gives two bands at zero time, one the same size 
as that produced initially by the wild-type cDNA and 
one slightly larger. The larger band presumably repre­
sents the fraction of the enzyme in which the fifth glyco- 
sylation site, an extra site introduced by the mutation, 
is utilized. Third, a smaller fraction of radioactivity is 
secreted, as was also observed for the catalytic activity 
(table 1). Fourth, the radioactive D 152N  enzyme disap­
pears with time, the total radioactivity falling to ~ 6 0% 
of that present at the zero time point by 24 h. Thus, 
the D 152N  enzyme shows accelerated degradation in 
comparison with the wild-type enzyme.
Since active [3-glucuronidase is a homotetramerie p ro­
tein, D 152N  subunits might have a dominant negative 
effect on wild-type subunits in mixed tetramers, To ad­
dress this question, the wild-type and the D 152N  
cDNAs were coexpressed in COS cells, using equimolar 
amounts of each expression vector (table 3). The enzyme 
activity measured in cells coexpressing both cDNAs 
(52% of wild type alone), was slightly lower than the 
average of the enzyme activities expressed separately
F i g u  1*6 2  Independent segregation of the D152N (nucleotide 
change 480G~*A) and L176F (nucleotide change 552C->T) mutations. 
E xon  3 of the p-glucuronidase gene was partially amplified with prim­
ers 3f-HUG10. PCR products were directly sequenced with primer 





GGC TAC CTC CCC TTC GAG GCC GAC
pseudodeficient tompiate GGC TAC CTC CCC TTC GAG GCC AAC
tion of the D152N enzyme increased 4.6 times the low 
level secreted in the absence of N H 4C1, and the total 
amount produced increased 18% (table 2). These data 
suggest that the D152N enzyme is protected somewhat 
by NH4C1, which raises the pH  of internal com part­
ments and diverts a larger fraction of the enzyme from 
receptor-mediated delivery to lysosomes to the secretory 
pathway.
Figure 1 presents the data from a pulse-chase experi­
ment meant to compare the rate of turnover of the 
D152N enzyme to that of the wild-type enzyme. Follow­
ing metabolic labeling for 1 h, COS cells transfected 
with the wild-type and D152N cDNA were incubated 
for Q, 10, and 24 h before immunoprécipitation of the 
P-glucuronidase from the cell lysate and media. The im~ 
munoprecipitate from each time point of chase was ana­
lyzed by SDS-PAGE and fluorography, and the fluoro- 
grams were quantitated by laser densitometry. When 
one sums the secreted and intracellular radioactivity, it is 
evident that the wild-type enzyme shows no degradation 
over 24 h. There are several interesting differences be­
















Figure 3 PCR-based detection o f  the GUSBp allele. A3 Exon 3 
was partially amplified from genomic DNA with PCR, using primers 
designed to amplify the gene but not the pseudogene sequences: the 
antisense primer HUG 10 and a sense primer (RAF44) designed to 
introduce a Sail site in the normal allele but no t  in the pseudodeficient 
allele, with sequence 5 '-GCTACCTCCCCTTCGAGGTC-3 ' (cDNA 
position 4 6 0 -4 7 9 ) .  B, PCR products were digested with Sail and run 
on a 3 % agarose gel; results are shown for the pseudodeficient mother 
(Mrs. S.), her affected child (E.S,), the postulated unrelated pseudode­
ficient individual (B.G.), an unaffected unrelated individual found to 
be a carrier of the 480G-*A mutation during population screening, a 
homozygous normal individual, and the uncut fragment.
802 Am .]. Hum. Genet 57:798-804, 1995
Expression of Wild-Type and DI52N Mutant Enzymes in COS Cells
Table I
ß-GUJCURONIDASE ACTIVITY
Units/mg Cell Protein minus
Endogenous
Percent of Percent
C o n st r u c t Cell Media Total W ild Type Secretion
Wild t y p e ............ 1,697 709 2,406 100 30
D152N ................ 527 122 649 27 19
N o te .— COS cells grown in p60 plates were transiently transfected, using 10 jig of expression vector 
pJC119 containing wild-type or mutant (D152N) p-glucuronidase cDNA. At 76 h after transfection, the 
media were collected and the cells lysed in 0.6 ml of 0.25% deoxycholic acid (DOC). Cell lysates and media 
were assayed for p-glucuronidase activity by using 4-methyiumbeIliferyl-(3-D-glucuronide. One unit is die 
amount of activity that releases 1 nmol of 4 -methylumbelliferone/h. Values are averages of two different 
experiments.
(64%). This reduction was observed in cells (55% vs. 
6 6 %) and in media (41% vs. 57%).
Discussion
The genetic evidence presented here supports the hy­
pothesis that the D152N enzyme is encoded by a 
pseudodeficiency allele of the [3-glucuronidase gene. It 
was found in a healthy mother of a MPSVII child with 
low residual enzyme activity, and it was shown to be 
present on the allele that was not transmitted to her 
affected child (fig. 2). N o other mutation could be de­
tected in her cDNA, in sequencing the whole coding 
region of the gene. Moreover, the D152N change occurs 
in a conserved region in human, rat, and mouse
Table 2
Effect of NH 4CI on the Expression of Wild-Type and DI52N  
Enzymes in COS Cells
ß-G lu c u r o n id a se  Activity
(Units/mg Cell Protein minus
Endogenous)
N H 4CI Cell Media Total
Wild type:
— 1,933 558 2,491
Ü4 li * *+» » + 1,472 1,130 2,602
D152N:
24 h ..... ------ 816 67 883
24  h + 773 308 1,041
N o t e .—At 50 h after transfection, media were replaced with 2 ml 
of media with or without 15 mM  N H 4CI and 5 m M  mannose-6- 
phosphate. After 24 h, the media were collected and the cells lysed in 
0.25% DOC, Cel! lysates and media were assayed for [3-gliicuronidase 
activity as in table 1 .
(LPFEADI), and Escherichia coli (TPFEADV) P~gluc- 
uronidase (Jefferson et al. 1986; Nishimura et al. 1986; 
D’Amore et al. 1988), and expression of the mutated 
allele in COS cells resulted in a level of P-glucuronidase 
activity that was only 27% of wild-type enzyme activity 
(table 1). Finally, the D152N change was also found in 
an atypical MPSVII patient with low p-glucuronidase 
activity but with clinical features similar to those of a 
sibling with enzyme activity in the heterozygote range. 
In this patient a genuine MPSVII mutation was also 
found (R357X), but, unfortunately, because of lack of 
appropriate materials, we have not been able to demon­
strate that the D152N and R357X changes are present 
on different alleles and that the familial distribution of 
mutated and normal alleles explains the differences of 
P-glucuronidase activity between the family members.
Molecular studies in fibroblasts and expression of the 
D152N change in COS cells allow one to draw several 
conclusions concerning the mutated enzyme. The re­
duced P-glucuronidase activity is primarily due to accel­
erated degradation of the protein and not to lowered 
expression of the mRNA or reduced synthesis of the 
protein. Indeed, analysis of mRNA of fibroblasts of Mrs. 
S. showed the D152N and the L176F mRNAs are pres­
ent at equal levels, and the latter has been shown pre­
viously to be expressed at wild-type levels (Wu et al.
1994). Furthermore, the amount of mutant enzyme pres­
ent after a labeling period of 1 h in a pulse-chase experi­
ment in transiently transfected COS cells is only slightly 
reduced when compared with wild type. In contrast, 
40% of the metabolically labeled D152N enzyme is de­
graded during a 24 h chase period, whereas the wild- 
type enzyme remains undegraded (fig. 1). Moreover, 
when one compares the ratio of enzyme activity and 
radioactivity of the wild-type and the D152N enzymes 
secreted, our results suggest that the specific activity of
Table 3
Coexpression of Wild-Type and Mutant Enzymes in CO S Cells
Vervoort et al.: P-Glucuronidase Pseudodeficiency 803
p-G lu c u r o n id a se  A ctiv ity
Units/mg Cell Protein Minus
Endogenous
Percent of Percent
C o n s t r u c t  Cell Media Total Wild Type Secretion
Wild t y p e ................................ 1,810 616 2,426 100 25
D152N ................................... 581 86 667 28 13
Wild type + D 1 5 2 N ............ 995 255 1,250 52 20
N ote .— COS cells were transfected with wild-type and/or D 152N  cDNA (10 fig piasmid was used for 
each plate; for coexpression 5 of each construct was used). At 77 h after transfection cells were collected 
and P-glucuronidase activity was measured as described in table 1.
the enzyme toward artificial substrate is not significantly 
reduced by the mutation (558/1.4 and 67/0.2, respec­
tively; combining data presented in table 2 and in fig, 
1)» The D152N mutation reduces the fraction of enzyme 
secreted, which may be related to the additional glyco- 
sylation site, which is introduced by the mutation and 
which is partly utilized in COS cells (fig. 1). If phosphor- 
ylated, this additional oligosaccharide chain could im­
prove the efficiency of sorting of the newly synthesized 
D152N enzyme to lysosomes, and thereby reduce the 
fraction secreted. The enhanced secretion of the D152N 
enzyme by NH4C1 is consistent with this suggestion (ta­
ble 2; Gonzalez-Noriega et al. 1980). Coexpression ex­
periments of wild-type and D152N cDNAs in COS cells
have demonstrated some reduction of the activity as 
compared with the expected average of both cDNAs 
expressed separately, in cells as well as in media. An 
attractive hypothesis to explain this observation is a 
dominant negative effect of D152N monomers in mixed 
tetramers; thus, D152N monomers could decrease secre­
tion and increase cellular retention of mixed tetramers, 
possibly as a result of their additional glycosylation site.
The frequency of various pseudodeficiency alleles has 
been estimated, and was relatively high in some cases 
(for a review, see Thomas 1994). For example, 1 0 % -  
20% of the population may be carriers of the arylsulfa- 
tase A pseudodeficiency mutation. In the non-Jewish 
population, 32% -42%  of enzyme-defined carriers of 
Tay-Sachs disease carry the C739T-pseudodeficiency al­
lele of ¡^-hexosaminidase A, and 6%  carry the C745T- 
pseudodeficiency allele (Triggs-Raine et al. 1992; Cao 
et al. 1993). In a first attempt to estimate the frequency 
of the GUSBp allele of the (3-glucuronidase gene, we 
screened 100 unrelated Belgian individuals and found 
one carrier of the D152N change. Although this is only 
a rough estimate, the GUSBp allele might be more fre­
quent (0.5%) than MPSVII alleles. As for other diseases 
in which pseudodeficiency alleles exist, the identification
of a pseudodeficiency allele for P-glucuronidase could 
have important consequences on a practical level 
(Thomas 1994). It is still premature to make definitive 
conclusions about the phenotypical consequences of the 
GUSBp allele, since the presence of the D152N mutation 
in combination with certain other MPSVII alleles might 
be more deleterious than its combination with L176F in 
Mrs. S. Since p-glucuronidase deficiency mucopolysac­
charidosis (MPSVII) is a rather rare disease, the D152N 
allele may be more common than alleles known to pro­
duce MPSVII. Its major importance may be related to 
possible errors in prenatal diagnosis and to misdiagnosis 
of atypical patients.
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